Who we are

Novavax is a global biotechnology company focusing on driving value via our proven recombinant nanoparticle and Matrix-M™ technology through partnerships and R&D. To do this, we are focused on four value drivers: executing on current partnerships, developing our late-stage assets, driving additional partnerships and deals through our technology, and building a robust early-stage pipeline.

Our mission

We never rest in our quest to protect the health of people everywhere.

Novavax is here to make a difference. We’re a biotech company focused on developing life-saving vaccines to fight infectious diseases. 

We use solid science tested by decades of research to develop vaccines.

Our leadership

Our team has unparalleled experience developing vaccines, conducting early proof-of-concept and clinical development work, and executing successful partnerships for further development and commercialization. Their immense depth of experience is ideally suited to exponentially increase the public health impact of our recombinant protein-based nanoparticle and Matrix-M™ adjuvant technology, while driving value for the Company.

Meet our leadership team

Our partners

We seek and encourage meaningful partnerships and collaborations with leading pharmaceutical and biopharmaceutical organizations, research institutions, government agencies and foundations to further the impact of our proven technology

Learn about our partnerships

Our technology

Active pipeline

Commitments

The power & speed of nanoparticle technology

Our vaccine technology combines power and speed with the immunogenicity-enhancing properties of our Matrix-M™ adjuvant to efficiently produce highly immunogenic particles targeting some of the most pressing viral infectious diseases.

closeup of laptop
Learn about our unique technology

Our pipeline is more important than ever

Novavax has demonstrated its ability to produce viable, promising vaccine candidates for emerging infectious diseases.

woman in lab
Learn about our pipeline

Our commitments

As a global leader in vaccine development and research, we hold our commitments and honor our responsibilities with the goal of improving global health.

one hand holding a tree and one hand holding a globe
Learn about our commitments